|
시장보고서
상품코드
2148305
세계 및 미국의 동물용 의약품 시장 : 약물 유형별, 유형별, 적응증별, 동물 유형별, 투여 경로별, 제형별, 유통 채널별, 지역별Global and U.S. Veterinary Drugs Market, By Drug Type, By Type, By Indication, By Animal Type, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계 및 미국의 동물용 의약품 시장 및 미국의 동물용 의약품 시장은 2026년에 249억 580만 달러 규모로 추정되며, 2033년까지 481억 9,750만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 249억 580만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 9.90% | 2033년 시장 규모 예측: | 481억 9,750만 달러 |
세계 및 미국의 동물용 의약품 시장은 반려동물, 가축, 수생 생물의 질병 예방 및 치료에 사용되는 항생제, 구충제, 항염증제, 진통제 등의 의약품으로 구성된 중요한 부문입니다. 수의약품에 대한 수요는 전 세계적으로 반려동물의 ‘인간화’ 추세, 동물성 단백질 수요 확대, 인수공통감염병의 확산, 그리고 동물 복지에 대한 관심 증가에 힘입어 성장하고 있습니다.
미국에서는 미국 식품의약국(FDA) 산하 동물용 의약품 센터(FDA-CVM)가 주도하는 견고한 규제 시스템을 통해 동물용 의약품의 안전성, 유효성, 품질이 보장되고 있습니다. 세계적 차원에서는 가축 생산의 확대, 도시화, 그리고 동물 건강에 대한 인식 제고가 새로운 성장 기회를 창출하고 있는 한편, 항생제 내성 문제로 인해 의약품 개발 및 책임 있는 사용에 대한 혁신이 촉진되고 있습니다.
시장 역학
세계 및 미국의 동물용 의약품 시장은 반려동물 수의 증가, 동물성 단백질 소비 확대, 그리고 체계적인 가축 건강 관리에 대한 수요 증가에 힘입어 성장하고 있습니다. 바이오의약품, 전문 치료법, 혁신적인 약물전달 시스템 등 동물용 의약품의 발전으로 새로운 치료 옵션이 등장하고 있습니다. 또한 신흥 경제국에서의 동물 건강 관리 인프라 개선으로 동물용 의약품에 대한 접근성이 확대되고 있습니다.
그러나 유기농 캡슐 시장의 성장은 엄격한 규제 요건, 항생제 내성에 대한 우려 증가, 높은 수의학 비용 등의 요인에 의해 제한받고 있습니다. 그럼에도 불구하고, 예방적 동물 건강 관리에 대한 관심 증가, 디지털 수의학 서비스의 개발, 수산양식 분야의 건강 관리 강화, 그리고 항생제를 사용하지 않은 동물성 제품에 대한 수요 증가는 혁신적인 백신, 지속형 치료법, 정밀 의학에 기반한 수의학 분야에 큰 기회를 창출하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 및 미국의 동물용 의약품 시장에서 주요 기업 개요를 소개하고 있습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로 마케팅 담당자 및 기업 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 세계 및 미국 동물용 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 및 미국 동물용 의약품 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계 및 미국의 동물용 의약품 시장 : 약물 유형별, 2021-2033년
제5장 세계 및 미국의 동물용 의약품 시장 : 유형별, 2021-2033년
제6장 세계 및 미국의 동물용 의약품 시장 : 적응증별, 2021-2033년
제7장 세계 및 미국의 동물용 의약품 시장 : 동물 유형별, 2021-2033년
제8장 세계 및 미국의 동물용 의약품 시장 : 투여 경로별, 2021-2033년
제9장 세계 및 미국의 동물용 의약품 시장 : 제형별, 2021-2033년
제10장 세계 및 미국의 동물용 의약품 시장 : 유통 채널별, 2021-2033년
제11장 세계 및 미국의 동물용 의약품 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고문헌 및 조사 방법
KSMGlobal and U.S. Veterinary Drugs Market is estimated to be valued at USD 24,905.8 Mn in 2026 and is expected to reach USD 48,197.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 24,905.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.90% | 2033 Value Projection: | USD 48,197.5 Mn |
The global and U.S. veterinary drugs market is a significant segment comprising pharmaceuticals such as antibiotics, antiparasitic, anti-inflammatories, and analgesics used to prevent and treat diseases in companion animals, livestock, and aquatic species. The demand for veterinary pharmaceuticals is being driven globally by the increasing pet humanization, growing demand for animal-derived protein, increasing prevalence of zoonotic diseases, and growing focus on animal welfare.
In the U.S., the safety, efficacy and quality of veterinary drugs is ensured by a robust regulatory system led by the U.S. FDA's Center for Veterinary Medicine (FDA-CVM). On the global scale, growing livestock production, urbanization and heightened awareness of animal health are creating new opportunities for growth, while antimicrobial resistance is spurring innovation in drug development and responsible use.
Market Dynamics
The global and U.S. veterinary drugs market is driven by the rising pet population, increasing animal protein consumption, and rising demand for systematic livestock healthcare. Advancements in veterinary pharmaceuticals such as biologics, specialized therapies, and innovative drug-delivery systems, are creating extra treatment options, and the improvement of veterinary healthcare infrastructure in emerging economies is widening access to animal medicines.
However, the growth of organic capsules market is limited by factors such as stringent regulatory requirements, increasing concerns related to antimicrobial resistance and high veterinary treatment costs. Nevertheless, the growing trend toward preventive animal healthcare, development of digital veterinary services, increasing aquaculture health management and demand for antibiotic-free animal products are creating significant opportunities for innovative vaccines, long-acting therapies and precision-based veterinary treatments.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global and U.S. veterinary drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Virbac S.A., Ceva Sante Animale S.A., Dechra Pharmaceuticals Limited, Vetoquinol S.A., Phibro Animal Health Corporation, and Norbrook Laboratories Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global and U.S. veterinary drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global and U.S. veterinary drugs market
Market Segmentation
- Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Antibiotics
- Nonsteroidal Anti-inflammatory Drug
- Antiparasitic Drugs
- Antihistamines
- Antiemetic Drugs
- Anti-ulcer Agents
- Diuretics
- Anaesthetic Agents
- Anticancer Agents
- Hormonal and Hormone Replacement Agents
- Others
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generics
- Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Digestive System Disease
- Immunologic Disease
- Nervous System Disease
- Reproductive System Disease
- Respiratory System Disease
- Dermatological Disease
- Oncology
- Hormonal Disorder
- Cardiovascular Disease
- Others
- Animal Type Insights (Revenue, USD Mn, 2021 - 2033)
- Companion Animal
- Livestock
- Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Parenteral
- Topical
- Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
- Tablets and Capsules
- Suspensions and Emulsions
- Powders and Pastes
- Gels, Creams and Ointments
- Sprays
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Veterinary Hospitals
- Veterinary Clinics
- Retail Pharmacies
- Online Pharmacies
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Elanco Animal Health Incorporated
- Virbac S.A.
- Ceva Sante Animale S.A.
- Dechra Pharmaceuticals Limited
- Vetoquinol S.A.
- Phibro Animal Health Corporation
- Norbrook Laboratories Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global and U.S. Veterinary Drugs Market, By Drug Type
- Global and U.S. Veterinary Drugs Market, By Type
- Global and U.S. Veterinary Drugs Market, By Indication
- Global and U.S. Veterinary Drugs Market, By Animal Type
- Global and U.S. Veterinary Drugs Market, By Route of Administration
- Global and U.S. Veterinary Drugs Market, By Dosage Form
- Global and U.S. Veterinary Drugs Market, By Distribution Channel
- Global and U.S. Veterinary Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global and U.S. Veterinary Drugs Market, By Drug Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Nonsteroidal Anti-inflammatory Drug
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Antiparasitic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Antiemetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anti-ulcer Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anaesthetic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anticancer Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hormonal and Hormone Replacement Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global and U.S. Veterinary Drugs Market, By Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global and U.S. Veterinary Drugs Market, By Indication, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Digestive System Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunologic Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Nervous System Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Reproductive System Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Respiratory System Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Dermatological Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hormonal Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global and U.S. Veterinary Drugs Market, By Animal Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Companion Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global and U.S. Veterinary Drugs Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global and U.S. Veterinary Drugs Market, By Dosage Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablets and Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Suspensions and Emulsions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Powders and Pastes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Gels, Creams and Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global and U.S. Veterinary Drugs Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
11. Global and U.S. Veterinary Drugs Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dechra Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phibro Animal Health Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Norbrook Laboratories Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
